Product Information

TOPIRAMATE ER 50 MG SPRINKL CAP is a generic product labeled by NorthStar Rx LLC, priced at $3.3778 per EA under NDC 72603012101. Its NADAC has been published 173 times since May 3, 2023.

FDA first approved this application on Feb 1, 2021. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 50 MG SPRINKL CAP

topiramate
$3.3778per EA

Strength

50 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603012101

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210278

FDA Approved

2/1/2021

TE Code

AB2

On Market Since

1/1/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 50 MG SPRINKL CAP has been published 173 times since May 3, 2023, and over the history we have for it it has declined 54.8%. The table below summarizes its recorded NADAC range and movement.

Current price$3.3778 per EA
All-time high$7.4658 (Jul 12, 2023)
All-time low$3.3778 (Aug 19, 2026)
52-week high$5.5824
52-week low$3.3778
Median price$5.2508
Average price$5.4945
Largest weekly change-26.0% (Jul 17, 2024)
Weeks tracked173
Tracking sinceMay 3, 2023

Price History

1W

-7.9%

1M

-7.9%

3M

-5.3%

6M

-33.0%

1Y

-31.7%

3Y

-48.8%

5Y

N/A

All

-54.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 50 MG SPRINKL CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG SPRINKL CAP, manufactured by NorthStar Rx LLC, is $3.3778 per EA (NDC 72603012101), effective Aug 19, 2026.

How has the price of TOPIRAMATE ER 50 MG SPRINKL CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG SPRINKL CAP has declined 54.8%. It has been tracked across 173 weekly CMS publications since May 3, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG SPRINKL CAP?

Since May 3, 2023, the NADAC for TOPIRAMATE ER 50 MG SPRINKL CAP has ranged from a low of $3.3778 (Aug 19, 2026) to a high of $7.4658 (Jul 12, 2023), with a median of $5.2508 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 50 MG SPRINKL CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 50 MG SPRINKL CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 50 MG SPRINKL CAP?

TOPIRAMATE ER 50 MG SPRINKL CAP (NDC 72603012101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.